Drug Type DNA encoding mab |
Synonyms DMAb34 |
Target |
Action inhibitors |
Mechanism EBOV glycoprotein inhibitors(EBOV glycoprotein inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hemorrhagic Fever, Ebola | Preclinical | United States | 01 Nov 2018 | |
Hemorrhagic Fever, Ebola | Preclinical | United States | 01 Nov 2018 | |
Hemorrhagic Fever, Ebola | Preclinical | United States | 01 Nov 2018 |